Pall Corporation, a manufacturer of filtration, purification and separation, is partnering with the BioFactory Competence Center in Fribourg, Switzerland to launch new training courses focused on continuous bioprocessing advances.
The courses, set to launch early next year, will detail the state of the industry and the advantages and practical implications of transitioning from batch to semi (or fully) continuous bioprocess methodologies.
“As drug manufacturers look to shift from batch to continuous processing for both small and large molecule drugs, information-sharing and continued education have become key drivers of advancement,” said Peter Levison, senior marketing director of Downstream Processing at Pall Corporation. “These unique training courses have been designed around real-life situations, with hands-on access to enabling technologies, and we are proud to support them.”
In addition to the new courses, plans exist to build a dedicated continuous bioprocessing facility in Fribourg for education on, and application of, continuous bioprocessing technologies.